SCHEMBL6367405

SCHEMBL6367405

[CH2][C@@H]1Cc2cc(F)cc(-c3cc(OC)ccc3C)c2O1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AQP1 P29972 3/20 0.38
MAOB P27338 5/20 0.36
ACHE P22303 1/20 0.35
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
TSHR P16473 2/20 0.34
HSD17B10 Q99714 2/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
ALOX15 P16050 1/20 0.34
MAPK1 P28482 1/20 0.34
DPP4 P27487 2/20 0.33
PDE2A O00408 1/20 0.33
PDE10A Q9Y233 1/20 0.33
ABCB1 P08183 1/20 0.33
AR P10275 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
METAP1 P53582 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4597046 1.00 AQP1 (0.38) AQP1MAOBACHEKDM4EALDH1A1
SCHEMBL4714768 0.88 MAOB (0.36) AQP1MAOBACHEKDM4EALDH1A1
SCHEMBL4597048 0.86 PARP1 (0.43) AQP1MAOBACHEKDM4EALDH1A1
SCHEMBL4712083 0.85 CYP1A1 (0.40) AQP1MAOBALDH1A1GAAMAPK1
SCHEMBL4596814 0.85 AQP1 (0.40) AQP1MAOBACHE
SCHEMBL4595373 0.84 MAOB (0.38) AQP1MAOBMAPTABCB1
SCHEMBL4236034 0.83 AQP1 (0.57) AQP1MAOBDPP4SLC6A2SLC6A4
SCHEMBL4711420 0.82 MAOB (0.35) MAOBACHEKDM4EALDH1A1MAPT
SCHEMBL4596825 0.82 AQP1 (0.52) AQP1PDE2APDE10A
SCHEMBL4222416 0.81 AQP1 (0.47) AQP1MAOBKDM4EALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050261347-A1 Dihydrobenzofuranyl alkanamine derivatives and methods for using same WYETH (US) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261347-A1 Dihydrobenzofuranyl alkanamine derivatives and methods for using same ADRA2A, HTR2A, ADRA1A AQP1 2290/4885MAOB 50/4885ACHE 662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.